Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure

Leong M, Dai T, Tong L, Nast CC. A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin[...]

CJASN: A Prelude to the Future

Rhee CM; CJASN Editorial Team. CJASN: A Prelude to the Future. Clin J Am Soc Nephrol. 2024 Nov 7. doi: 10.2215/CJN.0000000613. Epub ahead of print.[...]

Establishing a peritoneal dialysis technique survival core outcome measure: A standardised outcomes in nephrology-peritoneal dialysis consensus workshop report

Elphick EH, Manera KE, Viecelli AK, Craig JC, Cho Y, Ju A, Shen JI, Wilkie M, Anumudu S, Boudville N, Chow JS, Davies SJ, Gooden[...]